MOOSE Guidelines Explained: How to Report Meta-Analyses of Observational Studies

Research Impact

Interesting topics

MOOSE Guidelines Explained: How to Report Meta-Analyses of Observational Studies

Table of Content
1. What Are the MOOSE Guidelines?
2. Why MOOSE Is Essential for Observational Meta-Analyses
3. Core Components of the MOOSE Checklist
4. How MOOSE Complements Other Reporting Guidelines
5. Common Reporting Errors MOOSE Helps Prevent

The Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines provide a 35-item checklist designed to improve the reporting quality, transparency, and reproducibility of systematic reviews and meta-analyses, particularly those using observational data. It covers six key areas: background, search strategy, methods, results, discussion, and conclusion. These MOOSE reporting guidelines serve as an essential checklist for meta-analysis reporting, particularly for researchers conducting a meta-analysis of observational studies within epidemiology.

Meta-analyses are very needed in the field of evidence-based medicine, especially when a randomized controlled trial (RCT) may not be possible, ethical or practical. The key problem with observational research is that it is completely prone to biases, confounding and heterogeneity. To deal with this, the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines were created to force researchers to give more transparency, reproducibility, and rigor and standardize how observational studies are reported. These meta-analysis reporting standards are particularly relevant for observational study meta-analysis, where bias assessment in observational meta-analysis is critical for reliable evidence synthesis.

This article contains a structured summary of the MOOSE guidelines and their major components as well as some practical tips to assist authors of a meta-analysis of an observational study. It is intended to support researchers seeking guidance on systematic review and meta-analysis guidelines, as well as those engaging with epidemiology meta-analysis methods.

1. What Are the MOOSE Guidelines?

The MOOSE guidelines were developed in 2000 to provide recommendations for reporting systematic reviews and meta-analyses of epidemiological observational studies. While PRISMA has a broader range of use, MOOSE is limited by the concerns that are associated with the analysis of observational data, such as confounding bias and the inability to account for that bias through statistical methods at the time of data collection [1].

As reporting guidelines for observational studies, MOOSE focuses on transparency and methodological clarity rather than study appraisal. The primary goals of MOOSE are to:

Increase the quality and completeness of reporting for systematic reviews and meta-analyses of observational studies in the field of epidemiology.
Decrease the potential for selection bias due to selective outcome reporting; and
Increase the ease with which pooled observational evidence can be evaluated and interpreted.

MOOSE does not judge study quality—it ensures that readers can see clearly how decisions were made during evidence synthesis

2. Why MOOSE Is Essential for Observational Meta-Analyses

Observational research dominates many research disciplines, such as prognostic studies, risk factors, environmental effect studies, and public health outcome investigations; without a standardised method of reporting, meta-analyses can either overestimate the strength of an observed association or hide bias. This underscores the importance of systematic review and meta-analysis guidelines tailored specifically to observational study meta-analysis.

MOOSE assists authors in:

Explicitly reporting the inclusion criteria for their studies
Transparently assessing the heterogeneity between studies
Describing how they adjusted for confounding variables/studies
Justifying their choice of statistical models [2,3]

Researchers seeking meta-analysis writing services can use the MOOSE guidelines to ensure structured, transparent, and methodologically rigorous reporting.

3. Core Components of the MOOSE Checklist

The MOOSE checklist consists of 35 reporting items, organised into key methodological domains. As a checklist for meta-analysis reporting, it promotes consistency across epidemiology meta-analysis methods and reporting practices.

3.1. Background and Study Objectives

The author must identify:

The scientific basis for the study.
The relationship between exposure and outcome; and
The hypothesis that has been tested.

This section provides context for the need for observational evidence.

3.2. Search Strategy and Data Sources

MOOSE focuses on reproducibility from literature reviews. Required reporting elements include the following:

Databases searched.
Terms and combinations used to search.
Date range for searching.
Restrictions on language used in articles searched.

The Key Reporting Domains in the MOOSE Guidelines include:

Domain	Key Focus	Reporting Expectation
Background	Scientific rationale	Clear research question
Search Strategy	Data sources	Reproducible methods
Study Selection	Eligibility criteria	Explicit inclusion/exclusion
Data Extraction	Variables collected	Duplicate extraction
Analysis	Statistical methods	Justified model choice

3.3. Study Selection and Eligibility Criteria

Authors should detail the following information about their studies:

The types of methodological approaches (e.g., cohort, case-control, cross-sectional),
Descriptive characteristics of the samples (i.e., population), and
How exposure(s) and outcome(s) were quantified.

Furthermore, providing transparency to recruitment eligibility helps to minimise sampling bias.

3.4. Assessment of Bias and Confounding

Bias evaluation will be a cornerstone to the MOOSE reporting process.

With respect to bias evaluation, authors must report the following:

The methods used to evaluate the existence of bias
The process for handling any confounding variables
Conduct of a sensitivity analysis

This structured approach strengthens bias assessment in observational meta-analysis and improves interpretability.

If smoking is a confounder in a cancer meta-analysis, authors must explain whether adjusted or unadjusted estimates were pooled and why.

3.5. Statistical Analysis and Heterogeneity Reporting

MOOSE recommends providing detailed descriptions of:

Fixed and Random-Effect Models
Heterogeneity Metrics (e.g., I² and Q-Test)
Analytical Subgrouping and Sensitivity Tests

MOOSE requires interpretation for samples classified using measures of heterogeneity as opposed to solely reporting them [4,5].

4. How MOOSE Complements Other Reporting Guidelines

MOOSE should be used alongside:

PRISMA 2020 for flow diagrams [6]
STROBE for evaluating included studies [7]
GRADE for certainty assessment [8]

Using multiple guidelines strengthens methodological credibility and journal acceptance. This integrated approach aligns with best practices in systematic review and meta-analysis services and academic research reporting services.

5. Common Reporting Errors MOOSE Helps Prevent

The MOOSE guidelines help prevent common reporting errors in observational meta-analyses, including pooling unadjusted estimates without clear justification, failing to account for residual confounding, and overstating causal relationships. They also emphasise the need for thorough exploration and transparent reporting of heterogeneity, encouraging authors to interpret variability across studies rather than merely reporting statistical measures.

Reporting practices shape how evidence is understood, evaluated, and ultimately trusted.

In meta-analyses of observational studies, where bias and confounding are unavoidable realities, transparent reporting determines whether findings inform practice or mislead it. The MOOSE guidelines do not restrict scientific interpretation; they illuminate it—allowing readers, reviewers, and policymakers to critically appraise how evidence was assembled and synthesized.

Connect with us to explore how we can support you in maintaining academic integrity and enhancing the visibility of your research across the world!

Conclusion

Meta-analyses in epidemiological and clinical studies are very useful; however, they are limited by the presence of bias, confounding, and heterogeneity (the variable nature of the observations). The MOOSE guidelines are intended to deal with these challenges through structured and transparent reporting with high methodological quality. Adhering to MOOSE will provide authors with a means to document clearly their decisions concerning study selection, bias assessment, and analysis, so that findings can be interpreted within an epidemiological framework that is appropriate. Since observational evidence is increasingly being used to inform policy and practice in the clinical setting, the introduction of MOOSE will enhance the credibility, reproducibility, and practical usefulness of meta-analytic studies. High-quality publication support for meta-analysis increasingly requires adherence to established reporting frameworks such as the MOOSE guidelines.

Need expert guidance on applying MOOSE reporting guidelines to your research?
Pubrica offers comprehensive systematic review and meta-analysis services, including bias assessment, checklist compliance, and journal-ready reporting support. [Get Expert Publishing Support] or [Schedule a Free Consultation].

References

Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283(15), 2008–2012. https://doi.org/10.1001/jama.28
Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.), 315(7109), 629–634. https://doi.org/10.1136/bmj.315.710
Greenland S. (1987). Quantitative methods in the review of epidemiologic literature. Epidemiologic reviews, 9, 1–30. https://doi.org/10.1093/oxford
Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21(11), 1539–1558. https://doi.org/10.1002/sim.1186
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled clinical trials, 7(3), 177–188. https://doi.org/10.1016/0197-2456(86)90046-2
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.), 372, n71. https://doi.org/10.1136/bmj.n71
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & STROBE Initiative (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (London, England), 370(9596), 1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011). GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of clinical epidemiology, 64(4), 380–382. https://doi.org/10.1016/j.jclinepi